Aswanth Reddy Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Arkansas – Fort Smith

faculty

4 h-index 24 pubs 26 cited

Research Areas

Cancer Treatment and Pharmacology Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers Genomics and Rare Diseases Lung Cancer Diagnosis and Treatment Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Cancer Genomics and Diagnostics

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Aswanth Reddy's research focuses on the application of advanced therapies and diagnostic approaches in oncology. His recent publications explore bispecific antibodies and antibody-drug conjugates in lung cancer treatment, as well as responses to immunotherapy in patients with specific genetic mutations. Reddy has also investigated the cardiovascular effects of anti-androgen therapies and the successful treatment of HER2-mutated colorectal cancer with fam-trastuzumab deruxtecan.

Further research areas include the impact of germline genetic mutations in breast cancer patients and the performance of multi-cancer detection tests. He has also documented rare findings such as spontaneous pneumothorax during tyrosine kinase inhibitor treatment for synovial sarcoma. Reddy collaborates with several faculty members at the University of Arkansas – Fort Smith, including Maha Zafar and Nkolika Nwankwo, with whom he has co-authored multiple publications.

Metrics

  • h-index: 4
  • Publications: 24
  • Citations: 26

Selected Publications

  • Abstract PS5-04-16: Analysis of Efficacy, Safety and Cost of Datopotamab Deruxtecan and Sacituzumab Govitecan for Advanced Hormone Positive Breast Cancer Patients (2026) DOI
  • Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102) (2026) DOI
  • Mortality trends of chronic lymphocytic leukemia and pneumonia in the United States (1999–2023): A CDC-wonder analysis (2025) DOI
  • Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status (2025) DOI
  • Rising mortality trends in elderly multiple myeloma patients with hypertension: A CDC wonder database analysis (1999–2023) (2025) DOI
  • Comparative efficacy of complement inhibitors in complement Inhibitor–Naïve PNH: A network meta-analysis of randomized trials (2025) DOI
  • AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy (2025) DOI
  • A Rare Finding of Secondary Spontanous Pneumothorax (SSP) During Tyrosine Kinase Inhibitor Treatment of a Patient With Metastatic Synovial Sarcoma (2025) DOI
  • Treatment of Aggressive B Cell Lymphoma with Epcoritamab - Real World Single Institution Experience (2024) DOI

Collaborators

Researchers in the database who share publications

Maha Zafar University of Arkansas – Fort Smith 20 shared publications Nkolika Nwankwo University of Arkansas – Fort Smith 12 shared publications Muhammad G. Arnous University of Arkansas – Fort Smith 3 shared publications Keerthi Sripathi University of Arkansas – Fort Smith 2 shared publications Daphne Macbruce University of Arkansas – Fort Smith 1 shared publication Runa Shrestha University of Arkansas – Fort Smith 1 shared publication Saloni Shirke University of Arkansas – Fort Smith 1 shared publication

Similar Researchers

Based on overlapping research topics

David P. Douglass University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Genomics and Rare Diseases Cardiovascular Function and Risk Factors
Good match 5 shared topics
Andrew J. Pierce Ouachita Baptist University
Cancer Treatment and Pharmacology Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers
Good match 4 shared topics
Nkolika Nwankwo University of Arkansas – Fort Smith
Cancer Treatment and Pharmacology Lung Cancer Diagnosis and Treatment Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
David P. Douglass University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Matthew Henry University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Monoclonal and Polyclonal Antibodies Research Lung Cancer Diagnosis and Treatment
Good match 3 shared topics
Abdul Rafae University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer Immunotherapy and Biomarkers Cardiovascular Function and Risk Factors
Good match 4 shared topics